Document is current
Any future updates will be listed below
-
Authors
Wilde, Justin H. https://orcid.org/0000-0001-6076-5484
Sun, Yu-Yo
Simpson, Spenser R.
Hill, Ethan R. https://orcid.org/0009-0004-3816-1771
Fu, Zhongxiao https://orcid.org/0000-0002-8850-6991
Bian, Emily J.
Kinkaid, Melissa M.
Villanueva, Paulina
Weybright, Aden F.
Terrell, William R.
Qureshi, Zoraiz
Perera, Shashika S.
Sheppard, Heather S.
Stone, James R.
Kundu, Bijoy K.
Kuan, Chia-Yi
Neumann, Kiel D. https://orcid.org/0000-0001-9093-3522
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (R01EB028338)
American Lebanese Syrian Associated Charities
U.S. Department of Health & Human Services | National Institutes of Health (R01NS125788, R01NS125677, R21NS127392, R21HD109025)
- License Information
-
More Information
Article History
Received: 18 February 2024
Accepted: 30 January 2025
First Online: 5 March 2025
Competing interests
: K.D.N., J.H.W. and S.R.S. were listed as inventors of a clinically translatable ROS/RNS molecular imaging agent using a radiolabelled derivative of edaravone, a US patent application 63/530,889 filed in August 2023. The other authors declare no competing interests.
